10x Genomics Inc.

NASDAQ: TXG · Real-Time Price · USD
13.24
-0.33 (-2.43%)
At close: Aug 14, 2025, 3:59 PM
13.40
1.21%
After-hours: Aug 14, 2025, 07:30 PM EDT
-2.43%
Bid 12.95
Market Cap 1.65B
Revenue (ttm) 624.66M
Net Income (ttm) -157.04M
EPS (ttm) -0.7
PE Ratio (ttm) -18.91
Forward PE -13.09
Analyst Buy
Ask 13.4
Volume 5,447,758
Avg. Volume (20D) 3,740,022
Open 13.70
Previous Close 13.57
Day's Range 12.85 - 13.93
52-Week Range 6.78 - 24.76
Beta 2.03

About TXG

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TXG
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for TXG stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

10x Genomics has released their quartely earnings on Aug 7, 2025:
  • Revenue of $172.9M exceeds estimates by $33.42M, with 12.93% YoY growth.
  • EPS of 0.28 exceeds estimates by 0.47, with 187.50% YoY growth.
  • Next Earnings Release

    10x Genomics Inc. is scheduled to release its earnings on Oct 28, 2025, during market hours.
    Analysts project revenue of ... Unlock content with Pro Subscription
    1 week ago
    -3.98%
    TXG stock has given up its prior gain. 10x Genomic... Unlock content with Pro Subscription
    1 week ago
    -3.98%
    10x Genomics shares are trading higher after the company reported better-than-expected Q2 financial results and announced it will acquire Scale Biosciences. Also, Barclays raised its price target on the stock from $13 to $15.